Sevion Therapeutics CEO Sumit Aggarwal's 2022 pay falls 75% to $1.4M
Sevion Therapeutics reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Sevion Therapeutics reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Sevion Therapeutics received on average a compensation package of $740K, a 76% decrease compared to previous year.
Average pay of disclosed executives at Sevion Therapeutics
Sumit Aggarwal, Chief Executive Officer, received $1.4M in total, which decreased by 75% compared to 2021. 41% of Aggarwal's compensation, or $575K, was in salary. Aggarwal also received $253K in non-equity incentive plan, $556K in option awards, as well as $12K in other compensation.
Vijay Modur, Head of Research and Development, received a compensation package of $759K, which decreased by 77% compared to previous year. 61% of the compensation package, or $460K, was in salary.
Daniel E. Geffken, Chief Financial Officer, earned $64K in 2022, a 51% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.